DeVries J Hans, Wentholt Iris M E, Masurel Nathalie, Mantel Itske, Poscia Alessandro, Maran Alberto, Heine Robert J
Academic Medical Center Amsterdam, Department of Internal Medicine, The Netherlands.
Diabetes Metab Res Rev. 2004 Nov-Dec;20 Suppl 2:S43-6. doi: 10.1002/dmrr.513.
Hypoglycaemia is inevitable when striving for low HbA1c values. Nocturnal hypoglycaemia often occurs without symptoms, but results in diminished next day well-being and hypoglycaemia unawareness. Frequency of nocturnal hypoglycaemia was first assessed in research ward settings, but suffered from insufficient glucose sampling frequency. This may have resulted in overestimation of the duration of hypoglycaemic episodes. The advent of the first continuous glucose sensor, the needle-type MedtronicMiniMed Continuous Glucose Measurement System, revolutionized the assessment of glucose values. However, on scrutiny, the first version of this sensor showed a drift into the hypoglycaemic area and delayed recovery from hypoglycaemia. Using the microdialysis-based GlucoDay system, our group reported a lower frequency of nocturnal hypoglycaemia in type 1 diabetes patients using an insulin pump, than that expected from the existing literature. Today, more than 80 years after the introduction of insulin for the treatment of type 1 diabetes, the associated frequency of nocturnal hypoglycaemia still awaits its definitive assessment.
在努力实现低糖化血红蛋白(HbA1c)值时,低血糖是不可避免的。夜间低血糖常常在没有症状的情况下发生,但会导致次日身体不适以及低血糖无意识现象。夜间低血糖的发生频率最初是在研究病房环境中评估的,但存在葡萄糖采样频率不足的问题。这可能导致对低血糖发作持续时间的高估。首个连续血糖监测仪——针型美敦力MiniMed连续血糖测量系统的出现,彻底改变了血糖值的评估方式。然而,经过仔细审查,该监测仪的首个版本显示会漂移至低血糖区域,且从低血糖状态恢复的时间延迟。使用基于微透析的GlucoDay系统,我们团队报告称,使用胰岛素泵的1型糖尿病患者夜间低血糖的发生频率低于现有文献预期。如今,在胰岛素用于治疗1型糖尿病已过去80多年后,夜间低血糖的相关发生频率仍有待最终评估。